Less activity linked to fatigue across illnesses, including MS

Less activity linked to fatigue across illnesses, including MS
Credibility
Interest
Share:1 min read
Key Takeaway

A review found that less movement and more time sitting were linked to fatigue across several long-term illnesses, including MS.

What They Found

Researchers reviewed studies that used wearable devices to measure signs linked to fatigue. Across several long-term illnesses, people with more fatigue tended to be less active. They also tended to spend more time sitting. Changes in how the body controls automatic functions, such as heart rate, were also linked to fatigue. The strength of these links, and which measurements mattered, varied by illness.

Who Should Care and Why

The review covered people with MS and people with other long-term illnesses. It focused on fatigue measured by people's own reports. It compared those reports with measurements from wearable devices. The findings may help researchers study fatigue in different illnesses. The abstract does not say which wearable measurements were most useful for MS.

Important Considerations

You cannot tell from these findings whether less activity causes fatigue or fatigue leads to less activity. The review does not report how many people took part in the included studies. You also cannot tell from the abstract whether wearables can guide fatigue care for people with MS.

AI-generated summary — for informational purposes only, not medical advice

You May Also Like

Childhood MS blood patterns linked to Epstein-Barr virus
Childhood MS blood patterns linked to Epstein-Barr virus

11/1/2026

Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN

Read More
Stem Cell Treatment May Calm MS Brain Inflammation
Stem Cell Treatment May Calm MS Brain Inflammation

11/1/2026

In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for

Read More
New Brain Scans May Reveal Hidden Inflammation in MS
New Brain Scans May Reveal Hidden Inflammation in MS

11/1/2026

A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method

Read More
Could Red Blood Cells Help Calm MS Immune Attacks?
Could Red Blood Cells Help Calm MS Immune Attacks?

10/9/2026

A mouse study suggests prepared red blood cells may calm MS-like immune attacks. Learn why liver cel

Read More
A New Immune Approach May Ease MS-Like Disease in Mice
A New Immune Approach May Ease MS-Like Disease in Mice

10/7/2026

A 3D-printed immune implant eased advanced MS-like disease in mice without broadly weakening immunit

Read More
MS Study Finds Hidden Immune Cells That Treatment Targets
MS Study Finds Hidden Immune Cells That Treatment Targets

10/6/2026

Researchers found immune cells that swap surface tags in MS. An MS treatment removed them in the stu

Read More
Understanding MS Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like NPJ digital medicine often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.